Invacare (Invacare) EBIT per Share : $-2.24 (TTM As of Mar. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Invacare EBIT per Share?

Invacare's EBIT per Share for the three months ended in Mar. 2023 was $-0.82. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $-2.24.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Invacare's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Invacare was 42.70% per year. The lowest was -39.60% per year. And the median was 9.50% per year.

IVCRQ's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 5.9
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Invacare's EBIT for the three months ended in Mar. 2023 was $-31.1 Mil.

Invacare EBIT per Share Historical Data

The historical data trend for Invacare's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invacare EBIT per Share Chart

Invacare Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

-0.17

-0.44

0.12

-0.42

-1.90

Invacare Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EBIT per Share	Get a 7-Day Free Trial															-0.47	-0.41	-0.69	-0.32	-0.82

Invacare EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Invacare's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-69.481	/	36.629
=	-1.90

Invacare's EBIT per Share for the quarter that ended in Mar. 2023 is calculated as

	EBIT per Share		(Q: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-31.136	/	37.9824
=	-0.82

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.24

Invacare (OTCPK:IVCRQ) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Invacare EBIT per Share Related Terms

Thank you for viewing the detailed overview of Invacare's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Invacare (Invacare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invacare Corp (OTCPK:IVCRQ) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Invacare Way, Elyria, OH, USA, 44035-4190

Website

https://www.invacare.com

Invacare Corp makes and distributes medical equipment used in non-acute care settings. Its products are primarily sold to home medical equipment providers, residential living operators, distributors, and government health services. The firm sells products in three categories: mobility and seating, lifestyle, and respiratory therapy. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, and positioning cushions. Its lifestyle products include manual wheelchairs, crutches, walkers, and homecare beds. Its respiratory products include stationary and portable oxygen concentrators and non-delivery oxygen technology. Invacare receives the largest proportion of revenue from sales in Europe.

Executives

Tenor Opportunity Master Fund, Ltd.	10 percent owner	810 SEVENTH AVENUE, SUITE 1905, NEW YORK NY 10019
Randel G Owen	director	C/O EMERGENCY MEDICAL SERVICES CORP, 6200 SOUTH SYRACUSE WAY, GREENWOOD VILLAGE CO 80111
Kimberly Herman	director	3 HUNTINGTON QUADRANGLE, STE 25, MELVILLE NY 11747
Marec Elden Edgar	director	1420 KENSINGTON ROAD, SUITE 220, OAK BROOK IL 60523
Elliot Bossen	10 percent owner	3100 TOWER BLVD, UNIVERSITY TOWER STE 1104, DURHAM NC 27707
Silverback Asset Management Llc	10 percent owner	1414 RALEIGH ROAD, SUITE 250, CHAPEL HILL NC 27517
Peter J. Kuipers	director	590 E. MIDDLEFEILD ROAD, MOUNTAIN VIEW CA 94043
Tenor Capital Management Co., L.p.	10 percent owner	810 SEVENTH AVENUE, SUITE 1905, NEW YORK NY 10019
Pm Manager Fund, Spc-segregated Portfolio 33	10 percent owner	190 ELGIN AVE, GEORGE TOWN, GRAND CAYMAN E9 KYI-9005
Dov Gertzulin	10 percent owner	C/O DG CAPITAL MANAGEMENT, LLC, 460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Dg Capital Management, Llc	10 percent owner	460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Endurant Capital Management Lp	10 percent owner	66 BOVET ROAD, SUITE 353, SAN MATEO CA 94402
Abraham T Han	director	51 MIDLAND AVENUE, WYCKOFF NJ 07481
Dg Value Partners Ii Master Fund, Lp	10 percent owner	460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Quang Minh Pham	10 percent owner	66 BOVET ROAD, SUITE 353, SAN MATEO CA 94402